Abstract
Crohn's disease ( CD) and ulcerative colitis ( UC) are the two principal forms of inflammatory bowel disease ( IBD). Animal studies show that bacteria are involved in the etiology of IBD, and much is now known about the inflammatory processes associated with CD and UC, as well as the underlying genetic, environmental, and lifestyle issues that can affect an individual's predisposition to these diseases. However, while a number of candidate microorganisms have been put forward as causative factors in IBD, the primary etiologic agents are unknown. This review discusses the potential role of luminal and mucosal microbial communities in the etiology of IBD, and outlines studies that have been made using a variety of biotherapeutic therapies, involving the use of antibiotics, probiotics, prebiotics, and synbiotics.
Original language | English |
---|---|
Pages (from-to) | 25-54 |
Number of pages | 30 |
Journal | Critical Reviews in Clinical Laboratory Sciences |
Volume | 46 |
Issue number | 1 |
DOIs | |
Publication status | Published - Feb 2009 |
Keywords
- Antibiotics
- Crohn's disease
- Colon
- Microbiota
- Mucosal bacteria
- Mycobacteria
- Prebiotics
- Probiotics
- Sulfate-reducing bacteria
- Synbiotics
- Ulcerative colitis
- Active Crohns disease
- Avium subspecies paratuberculosis
- Placebo controlled trial
- Randomized controlled trials
- Invasive escherichia coli
- Polymerase chain reaction
- Severe ulcerative colitis
- Antibiotic combination therapy
- Bifidobacteria fermented milk